OakChart

P3 Health Partners Inc

PIIIHealthcare·Medical Care Facilities·USA·Nano·NASD·Nov 11 • 1:56 PM ET

2.86-0.52 (-15.38%)
2026-11-11 20:00 CET
Market cap
13.57 USD m
Revenue, TTM
1,553.93 USD m
Net income, TTM
-75.97 USD m
Free cash flow, TTM
-115.67 USD m
EPS diluted, TTM
-23.26
P/E
-
Compare

Price

PIII against its 20, 50 and 200-day averages
2050200earnings
5.0010.0015.0032.8M65.7MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PIIIclose 2.8620-day 3.9450-day 5.80200-day 6.592.8652w high

83.1% under the 52-week high of 16.89 on 28 May 2026. 52-week low 1.52 on 2 Feb 2026. Last 15 sessions, 85.2% high to low

Profile

PIII
52-week range, 9% of the way up
1.5216.89

P3 Health Partners, Inc. is a population health care management company, which engages in the provision of professional support services to doctors and clinicians. The firm offers capital care model, data and technology, physician leadership, and community outreach tools to create patient outcomes and experiences. The company was founded by Sherif Abdou and Amir Bacchus on August 20, 2020 and is headquartered in Henderson, NV.

Employees320
IPOApr 06, 2021
Beta1.82
ATR, 14d0.52
Rel volume2.43
Short float0.70%
Insider own50.94%
Inst own7.97%

Snapshot

6 groups

Valuation

Index-
Market Cap20.76M
Enterprise Value385.50M
Income-75.97M
Sales1.55B
Book/sh-19.41
Cash/sh6.31
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees320
IPOApr 06, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S0.01
P/B-
P/C0.45
P/FCF-
EV/EBITDA141.21
EV/Sales0.25
Quick Ratio0.53
Current Ratio0.53
Debt/Eq1.23
LT Debt/Eq0.44
Option/ShortNo / Yes

Earnings

EPS (ttm)-23.26
EPS next Y-11.51
EPS next Q-5.96
EPS this Y84.07%
EPS next Y-59.64%
EPS next 5Y45.87%
EPS past 3/5Y48.16% -2.64%
Sales past 3/5Y11.61% 24.33%
EPS Y/Y TTM42.43%
Sales Y/Y TTM7.54%
EPS Q/Q100.70%
Sales Q/Q14.80%
EarningsNov 09 AMC
EPS/Sales Surpr.101.77% 2.96%

Ownership

Insider Own50.94%
Insider Trans-1.32%
Inst Own7.97%
Inst Trans-5.16%
ROA-7.57%
ROE-115.66%
ROIC-33.14%
Gross Margin3.95%
Oper. Margin-5.24%
Profit Margin-4.89%
SMA20-27.48%
SMA50-50.69%
SMA200-56.57%
Trades-

Technical

Shs Outstand4.02M
Shs Float1.97M
Short Float0.70%
Short Ratio0.40
Short Interest0.01M
52W High16.89 -83.07%
52W Low1.52 88.16%
Volatility14.92% 12.39%
ATR (14)0.52
RSI (14)27.98
Beta1.82
Rel Volume2.43
Avg Volume34.20K
Volume58,518

Performance

Perf Week-30.24%
Perf Month-29.03%
Perf Quarter-73.89%
Perf Half Y-19.89%
Perf YTD-18.05%
Perf Year-61.92%
Perf 3Y-95.76%
Perf 5Y-99.43%
Perf 10Y-
Recom2.00
Target Price13.50
Prev Close3.38
Price2.86
Change %-15.38%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Aug 28, 2025ResumedLLake StreetBuy$20+599.3%
Apr 01, 2024DowngradeBBTIG ResearchBuy → Neutral
Sep 01, 2023InitiatedBBTIG ResearchBuy$5+74.8%
Jun 30, 2023InitiatedTTD CowenMarket Perform

Peers

Mkt cap
TickerCompanyMkt cap
AGLAgilon Health Inc1.93B
ASTHAstrana Health Inc1.63B
INNVInnovAge Holding Corp1.27B
PRVAPrivia Health Group Inc3.07B
DCGODocGo Inc23.00M
NUTXNutex Health Inc1.31B
ALHCAlignment Healthcare Inc1.62B
CLOVClover Health Investments Corp2.65B
EVHEvolent Health Inc550.26M
CYHCommunity Health Systems Inc306.74M

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Hudson Vegas Investment SPV, L10% OwnerAug 10 '26Sale16.4850,000823,9270Aug 12 04:30 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-090.070-3.965-396.34384.952
2026Q22026-08-10-0.630-1.895-0.632386.38377.82
2026Q12026-05-140.320-4.8500.318386.39391.452
2025Q42026-03-26-23.020-8.063-23.017384.81353.683
2025Q32025-11-13-9.670-5.293-9.666345.25347.054
2025Q22025-08-14-6.230-5.855-6.233355.79358.185
2025Q12025-05-15-6.280-8.163-6.282373.23358.355
2024Q42025-03-27-18.000-4.095-20.820370.69378.065
2024Q32024-11-12-15.500-1.845-15.698362.12364.434
2024Q22024-08-07-7.500-2.200-7.371379.16383.545
2024Q12024-05-08-8.000-6.360-7.865388.5352.555
2023Q42024-03-28-11.000-5.480-11.042346.86302.974
2023Q32023-11-08-6.000-8.965-5.963288.35293.425
2023Q22023-08-07-4.500-6.495-4.568329.09303.933
2023Q12023-05-10-11.000-23.285-11.062302.08282.893
2022Q42023-03-31-113-45.560-113.07258.2252.962

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY--38.500-188.17642642
2022FY-325-256.87-324.841,0501,044
2023FY-31.500-37.015-30.4431,2661,223
2024FY-47.000-28.011-54.0581,5001,508
2025FY-45.260-29.983-1,4591,428
2026FY--7.210--1,563
2027FY--11.510--1,726
2028FY--7.180--2,137

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10210399.35397401.7
2026Q4S2026-11-09200393.55385.4401.7
2026Q4S2026-10-25200393.55385.4401.7
2026Q4S2026-10-09210393.55385.4401.7
2026Q4S2026-08-26210393.35385401.7
2026Q4S2026-08-25210393.55385.4401.7
2026Q4S2026-08-11210395.1388.5401.7
2026Q4S2026-08-03200386.3384.1388.5
2026Q4S2026-07-29201386.3384.1388.5
2026Q4S2026-05-20202386.3384.1388.5
2026Q4S2026-05-15202395.2384.1406.3
2026Q4S2026-05-07211399.9393.5406.3
2026Q4S2026-04-17202394.45382.6406.3
2026Q4S2026-04-08302390.7382.6406.3

Estimate history

EPS, annual-39.73-188.174-324.836-30.443-54.058-45.258-23.263
Period202020212022202320242025TTM
EPS, quarterly-15.698-20.82-6.282-6.233-9.666-23.0170.318-0.6320.068
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual491.064637.3651049.4711266.3751500.4551459.081553.93
Period202020212022202320242025TTM
Sales, quarterly362.124370.686373.225355.788345.253384.814386.39386.381396.344
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual0.7910.8320.8322.3323.2573.2864.016
Period202020212022202320242025MRQ
Shares, quarterly3.2393.2573.2633.2633.2683.2863.2943.914.016
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue1,553.931,459.081,500.451,266.381,049.47637.36491.06
Cost of Goods Sold Incl. D&A1,492.611,603.401,645.431,321.411,144.51668.07485.30
Gross Profit61.32-144.32-144.97-55.04-95.04-30.705.77
Selling, General and Administrative Excl. Other128.65107.23113.93125.53162.38157.2454.89
Other Operating Expense14.0918.7553.70-12.71-11.460.00-20.54
Operating Income-81.42-270.30-312.60-167.86-245.96-187.95-28.59
Interest Expense45.3155.0322.1715.9811.4011.002.53
Unusual Expense3.36-7.85-14.06-0.361,305.095.390.00
Net Income Before Taxes-127.00-321.06-305.99-183.73-1,559.69-204.34-31.41
Income Taxes-10.752.024.392.691.860.000.00
Consolidated Net Income-116.25-323.09-310.38-186.43-1,561.56-204.34-31.41
Net Income From Continuing Operations-51.23-147.95-135.85-57.77-270.13-156.48-31.41
Net Income-75.97-147.95-135.85-57.77-270.13-156.48-31.41
EPS (Recurring)-10.89-46.94-57.40-30.58773.75-183.63-39.73
EPS (Basic, Before Extraordinaries)-23.14-45.26-46.79-30.44-324.84-188.17-39.73
EPS (Diluted)-23.26-45.26-54.06-30.44-324.84-188.17-39.73
EBITDA2.73-186.14-226.54-81.19-158.67-179.22-27.79
Non-Operating Income (Expense)3.09-3.5814.73-0.252.760.00-0.29
Other After Tax Adjustments0.000.000.000.000.000.000.00
Stock Option Compensation Expense2.054.414.544.1015.338.160.45
Price To Sales Ratio0.030.010.020.110.070.46-
Gross Margin3.95-9.89-9.66-4.35-9.06-4.821.17
Operating Margin-5.24-18.53-20.83-13.26-23.44-29.49-5.82
Net Margin-4.89-10.14-9.05-4.56-25.74-24.55-6.40
Shares Outstanding4.023.293.262.330.830.830.79
Market Capitalization13.5713.5736.63161.0976.51292.72309.59

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue396.34386.38386.39384.81345.25355.79373.23370.69
Cost of Goods Sold Incl. D&A367.04321.42357.10447.05390.82372.43393.10431.38
Gross Profit29.3064.9629.29-62.24-45.57-16.64-19.87-60.69
Selling, General and Administrative Excl. Other34.2732.3925.7736.2122.3923.4525.1831.83
Other Operating Expense-27.95-8.66-4.7155.41-23.74-5.97-6.9637.93
Operating Income22.9841.238.24-153.87-44.22-34.12-38.09-130.44
Interest Expense5.047.8616.7715.6420.5310.148.726.83
Unusual Expense-7.6116.37-0.33-5.072.54-2.00-3.320.57
Net Income Before Taxes30.8016.92-7.96-166.75-69.45-41.68-43.17-124.20
Income Taxes0.021.26-11.00-1.040.011.981.074.95
Consolidated Net Income30.7815.653.04-165.71-69.46-43.66-44.25-129.15
Net Income From Continuing Operations15.627.441.22-75.52-31.59-20.36-20.48-58.62
Net Income0.45-2.131.22-75.52-31.59-20.36-20.48-58.62
EPS (Recurring)-0.742.780.29-24.10-9.12-6.66-7.00-20.70
EPS (Basic, Before Extraordinaries)0.13-0.630.37-23.02-9.67-6.23-6.28-18.02
EPS (Diluted)0.07-0.630.32-23.02-9.67-6.23-6.28-20.82
EBITDA44.0262.2729.31-132.87-23.19-13.04-17.04-109.29
Non-Operating Income (Expense)5.25-0.080.24-2.32-2.160.580.3213.65
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense-0.330.680.830.870.961.161.430.57
Price To Sales Ratio0.030.020.020.010.020.010.020.02
Gross Margin7.3916.817.58-16.17-13.20-4.68-5.32-16.37
Operating Margin5.8010.672.13-39.98-12.81-9.59-10.21-35.19
Net Margin0.11-0.550.32-19.62-9.15-5.72-5.49-15.81
Shares Outstanding4.023.913.293.293.273.263.263.26
Market Capitalization13.5735.9210.1511.4729.2320.5926.7736.63

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments25.8144.1040.9318.46140.8339.90
Short Term Receivables95.84125.21121.4779.5952.0745.78
Inventories0.000.000.000.000.000.00
Other Current Assets11.4414.823.612.646.965.19
Total Current Assets133.08184.14166.02100.69199.8690.88
Net Property, Plant & Equipment15.8718.6323.9920.5415.0710.88
Total Investments and Advances0.000.000.000.000.000.00
Long-Term Note Receivable---3.503.593.98
Intangible Assets492.42574.35666.73751.052,145.590.87
Deferred Tax Assets2.85--0.17--
Other Assets12.676.304.230.790.000.00
Total Assets656.90783.42860.97876.742,364.11106.62
Short Term Debt Incl. Current Port. of LT Debt47.4467.502.701.603.620.09
Accounts Payable369.33319.10221.66176.36142.2482.47
Other Current Liabilities128.49109.8275.0163.7152.918.06
Total Current Liabilities545.26496.42299.37241.66198.7790.62
Long Term Debt239.85101.16121.94105.9486.3049.02
Provision for Risks Charges2.600.000.000.000.000.00
Deferred Tax Liabilities0.26--0.17--
Other Liabilities9.1736.315.996.3114.876.32
Total Liabilities797.13633.89427.31354.08299.94145.96
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-155.2375.94142.135.85273.55-130.04
Total Shareholders Equity-155.2375.94142.135.85273.55-130.04
Accumulated Minority Interest15.0073.59291.53516.801,790.6290.70
Total Equity-140.24149.53433.66522.662,064.17-39.34
Total Liabilities & Stockholders Equity656.90783.42860.97876.742,364.11106.62
Book Value Per Share-47.2423.3160.957.04328.95-164.47
Tangible Book Value Per Share-197.10-153.01-224.98-896.12-2,251.19-165.58
Full-Time Employees3203604006005002
Price to Book Ratio-0.170.480.860.981.071.01
Return on Assets-20.54-16.52-6.65-16.67-13.24-
Return on Equity--124.59-78.08-193.36-114.40-
Return on Invested Capital-174.84-76.71-21.88-241.64-43.49-
Quick Ratio0.240.370.550.421.011.00
Current Ratio0.240.370.550.421.011.00

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-116.25-323.09-310.38-186.43-1,561.56-204.34-31.41
Depreciation84.1584.1686.0686.6787.298.720.80
Other Funds (Non Cash)0.3862.9127.30-6.571,313.4353.36-19.87
Funds from Operations-28.36-173.14-198.10-106.33-160.84-142.25-50.48
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-87.4381.9187.9830.3034.8275.7825.89
Cash from Operating Activities-115.79-91.24-110.13-76.03-126.02-66.47-24.60
Capital Expenditures0.120.000.00-1.83-2.23-3.41-2.93
Net Assets From Acquisitions0.000.000.000.00-5.50-52.87-0.13
Sale of Fixed Assets and Businesses0.080.1314.530.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.00
Other Uses-0.250.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.210.11
Cash from Investing Activities-0.050.1314.53-1.83-7.73-56.073.17
Cash Dividends Paid0.000.000.000.000.000.000.00
Change in Capital Stock83.240.0040.0286.420.00195.31-0.18
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock83.240.0040.0286.420.00195.31-0.18
Proceedsfrom Stock Options83.240.00-0.4786.420.00195.31-0.18
Issuance or Reduction of Debt, Net41.0972.8158.8513.9311.3828.1634.94
Change in Long Term Debt40.0472.8156.9813.9314.9524.4334.94
Issuance of Long Term Debt39.9672.8187.9513.9315.0024.4334.94
Reduction of Long Term Debt0.080.00-30.970.00-0.050.000.00
Net Financing Active Other Cash Flow-0.000.00-0.10-0.020.000.000.00
Other Financing Activities Uses-0.000.00-0.10-0.020.000.000.00
Cash from Financing Activities123.1972.8198.77100.3311.38223.4734.76
Net Change in Cash7.34-18.303.1722.48-122.38100.937.00
Free Cash Flow-115.67-91.24-110.13-77.86-128.25-69.88-27.52
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-2.87-1.090.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments45.8022.1926.1025.8138.4639.33
Short Term Receivables154.49144.63133.9595.8485.76101.03
Inventories0.000.000.000.000.000.00
Other Current Assets15.7412.5212.1511.4411.4116.17
Total Current Assets216.03179.34172.21133.08135.63156.53
Net Property, Plant & Equipment2.152.532.9615.873.904.69
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets431.82452.40472.99492.42512.91533.40
Deferred Tax Assets---2.85--
Other Assets19.7320.1225.9912.6731.1236.97
Total Assets669.72654.39674.16656.90683.56731.59
Short Term Debt Incl. Current Port. of LT Debt84.5322.2252.2747.4438.7380.45
Accounts Payable233.22247.94345.81369.33317.07312.30
Other Current Liabilities88.90118.43127.40128.4968.16112.24
Total Current Liabilities406.65388.58525.49545.26423.95505.00
Long Term Debt47.33108.47270.40239.85226.24112.26
Provision for Risks Charges0.000.000.002.600.000.00
Deferred Tax Liabilities---0.26--
Other Liabilities15.0319.7011.449.1714.4527.14
Total Liabilities469.00516.75807.32797.13664.64644.41
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value185.24164.440.000.000.000.00
Common Equity-77.97-92.25-144.91-155.23-18.6944.46
Total Shareholders Equity107.2772.19-144.91-155.23-18.6944.46
Accumulated Minority Interest93.4465.4511.7415.0037.6142.72
Total Equity200.72137.64-133.17-140.2418.9387.18
Total Liabilities & Stockholders Equity669.72654.39674.16656.90683.56731.59
Book Value Per Share-19.41-23.59-43.99-47.24-5.7213.62
Tangible Book Value Per Share-126.94-139.30-187.58-197.10-162.67-149.84
Full-Time Employees---320--
Price to Book Ratio-0.17-0.25-0.07-0.610.660.33
Return on Assets-7.57-14.20-17.32-20.54-17.28-17.97
Return on Equity-115.66-168.78---257.39-138.17
Return on Invested Capital10.104.120.97-89.25-15.22-12.99
Quick Ratio0.530.460.330.240.320.31
Current Ratio0.530.460.330.240.320.31

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income30.7815.653.04-165.71-69.46-43.66
Depreciation21.0421.0421.0721.0021.0321.08
Other Funds (Non Cash)-32.78-42.799.6166.3411.15-6.43
Funds from Operations19.04-6.0934.20-75.51-37.28-29.02
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-19.72-55.82-61.6749.7821.8712.38
Cash from Operating Activities-0.69-61.91-27.47-25.73-15.41-16.63
Capital Expenditures0.000.000.000.12-0.120.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.080.000.05
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.00-0.21-0.040.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.00-0.21-0.040.20-0.120.05
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)--0.000.000.000.00
Change in Capital Stock24.6158.630.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock24.6158.630.000.000.000.00
Proceedsfrom Stock Options24.6158.630.000.000.000.00
Issuance or Reduction of Debt, Net-0.31-0.4227.8014.0114.6714.62
Change in Long Term Debt-0.31-0.4226.7614.0114.6714.62
Issuance of Long Term Debt0.000.0026.9712.9915.0114.96
Reduction of Long Term Debt-0.31-0.42-0.211.02-0.34-0.34
Net Financing Active Other Cash Flow0.00-0.000.000.000.000.00
Other Financing Activities Uses0.00-0.000.000.000.000.00
Cash from Financing Activities24.2958.2127.8012.8714.6714.62
Net Change in Cash23.61-3.910.29-12.65-0.86-1.97
Free Cash Flow-0.69-61.91-27.47-25.61-15.53-16.63

Revenue breakdown

Capitated2024: 1.48B 2025: 1.43B
Health Care Clinical Fees Insurance2024: 5.93M 2025: 3.06M
Health Care Coordination Management Fees2024: 10.56M 2025: 10.82M
Health Care Incentive Fees2024: 356.00K 2025: 16.22M
United States2024: 1.50B 2025: 1.46B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.70%0.0M2.0M32.15K
2026-10-150.57%0.0M2.0M33.02K
2026-09-300.71%0.0M1.9M35.75K
2026-09-151.43%0.0M1.9M39.64K
2026-08-311.66%0.0M1.6M53.29K
2026-08-142.06%0.0M1.6M1.25M
2026-07-312.52%0.0M1.4M1.27M
2026-07-152.68%0.0M1.4M1.29M
2026-06-303.42%0.0M1.4M1.27M
2026-06-154.79%0.1M1.4M1.25M
2026-05-299.73%0.1M1.4M1.29M
2026-05-1515.49%0.3M1.8M1.13M
2026-04-303.98%0.1M1.8M84.68K
2026-04-154.12%0.1M1.8M89.24K
2026-03-315.25%0.1M1.8M86.48K
2026-03-135.13%0.1M1.8M80.61K
2026-02-274.40%0.1M1.8M47.00K
2026-02-134.60%0.1M1.8M47.33K
2026-01-301.51%0.0M1.8M13.98K
2026-01-150.86%0.0M1.9M9.74K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-0910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-098-KCurrent report2026-11-09SEC
2026-11-06EFFECTEffectiveness filing by commission orderSEC
2026-10-15S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-09-118-KCurrent report2026-09-04SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-12SCHEDULE 13D/ASEC
2026-08-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-108-KCurrent report2026-08-10SEC
2026-07-068-KCurrent report2026-06-30SEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-108-KCurrent report2026-06-09SEC
2026-05-268-KCurrent report2026-05-20SEC
2026-05-184Statement of changes in beneficial ownership of securities2026-05-08SEC
2026-05-158-KCurrent report2026-05-14SEC
2026-05-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-148-KCurrent report2026-05-14SEC
2026-04-30DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-30DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-09SEC
2026-04-288-KCurrent report2026-04-27SEC
2026-04-20PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-09SEC
2026-04-03S-8Initial registration statement for securities to be offered to employees pursuant to employee benefit plansSEC
2026-03-2610-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-268-KCurrent report2026-03-26SEC
2026-03-258-KCurrent report2026-03-19SEC
2026-02-178-KCurrent report2026-02-11SEC
2026-01-234/A2025-08-06SEC
2026-01-234/A2025-08-06SEC
2026-01-234/A2025-08-06SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-0800823.93K1
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
HRT FINANCIAL LP1.65%
JANE STREET GROUP, LLC1.64%
VANGUARD CAPITAL MANAGEMENT LLC1.25%
Trinity Financial Advisors LLC0.94%
MYDA Advisors LLC0.60%
Diversified Trust Co0.60%
Corient Private Wealth LP0.59%
Scientech Research LLC0.49%
RENAISSANCE TECHNOLOGIES LLC0.46%
GEODE CAPITAL MANAGEMENT, LLC0.45%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND0.85%
VANGUARD EXTENDED MARKET INDEX FUND0.39%
Fidelity Extended Market Index Fund0.19%
Fidelity Total Market Index Fund0.08%
Fidelity Series Total Market Index Fund0.06%
Fidelity Nasdaq Composite Index Fund0.03%
VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND0.00%
Knights of Columbus U.S. ALL CAP INDEX FUND0.00%

OakChart. PIII. Cached 15 minutes.